Centre for Human Reproduction

Centre Director, Professor Michael Turner


Prof Michael Turner

Having graduated from UCD Medicine in 1978, Professor Michael Turner trained in obstetrics and gynaecology in Dublin and London, and was appointed as a consultant in 1990.  He earn his membership of both the Royal College of Physicians in Ireland and the Royal College of Obstetricians & Gynaecologists in 1984 and in 1988 was awarded a Masters of the Art of Obstetrics by University College Dublin.  

From 1992 to 1998 he served as Master of the Coombe Women and Infants University Hospital which is one of Europe's leading hospitals for women's healthcare.  In 2006 he was appointed the UCD Professor of Obstetrics and Gynaecology at the Coombe.  Since 2010 he has served as the country's first National Lead for the Health Services Executive Clinical Programme in Obstetrics and Gynaecology.

UCD Centre for Human Reproduction

Professor Turner is also Director of the UCD Centre for Human Reproduction at the Coombe Women's & Infants' University Hospital, one of the university's dedicated research centres.  The centre focuses on health services implementation science and on modifiable clinical risk factors for pregnancy such as maternal obesity, aberrant fetal growth, inadequate nutrition, infection and smoking.  

His full profile is available here.

Growing Issue of Maternal Obesity

Prof Turner discusses the growing issue of maternal obesity in an interview on Today with Sean O'Rourke (RTE Radio 1)


Established in 2007, the UCD Centre for Human Reproduction at the Coombe Women and Infants University Hospital was recognised in 2015 by the Academic Council as one of the university's designated research centres. 

The Director is Professor Michael Turner and the Centre's Advisory Board includes: Dr Brendan Egan, Prof Chris Fitzpatrick, Dr Mairead Kennelly, Prof Richard Layte, Dr Dan McCartney, Dr Jan Miletin, Dr Ann Molloy, Prof Carel le Roux, Prof Michael Turner.

The main research focus of the Centre is on modifiable pregnancy risk factors including maternal obesity, gestational diabetes mellitus, aberrant fetal growth, inadequate maternal diet, folic acid supplementation, cigarette smoking, infection and exercise. Since 2010, Professor Turner has served as the National Lead for the HSE Clinical Programme in Obstetrics and Gynaecology and, as a result, the Centre as also provided leadership on maternity services implementation science projects.

The Centre enables interdisciplinary research and has developed a strong collaborative relationship working on pregnancy and nutrition with Dr Dan McCartney and his colleagues at the School of Biological Sciences in the Dublin Institute of Technology.

In 2015, Professor Turner served on the

  • Food Safety Authority of Ireland's Advisory Group on Folic Acid Food Fortification
  • RCPI Policy Group on Obesity,
  • HIQA Advisory Ggroup on Standards in the Maternity Services
  • HIQA Technology Assessment Group
  • Department of Health's Advisory Group on Protection of Life During Pregnancy Act
  • National Clinical Effectiveness Committee (NCEC) Development Group for the Irish Maternity Early Warning System (IMEWS) Guideline
  • HSE Implementation Groups for Maternity Services
  • First National Maternity Strategy Report Group.

Improving the Diagnosis of Gestational Diabetes Mellitus

Thu, 3 March 16 16:41

UCD Researchers have demonstrated the impact of strict pre-analytical sample handling procedures on the diagnosis of gestational diabetes mellitus (GDM) in pregnant women.  The prospective observational study found that the prevalence of GDM was 2.7 times higher if standards for pre-analytic prevention of glycolysis in the maternal samples were strictly implemented compared with the customary hospital conditions.  These findings raise the possibility that suboptimal implementation of measures to prevent glycolysis is causing GDM to be under-diagnosed across the country, with potentially serious clinical consequences.

Centre Information